Overview
ProteinQure (Toronto) is looking to lead the charge in making Ontario a thriving hub of drug development and research, while focusing on breast cancer therapies.
What they’re doing: ProteinQure is testing the safety of their peptide-based tumour targeting drug ahead of a North American clinical trial.
How will this be used in the real world? We’re getting closer to personalized medicine and ProteinQure is working to raise the bar by designing anti-cancer therapies that are highly effective with less side effects for patients.